EMCURE PHARMACEUTICALS L Financial Ratios
EMCURE · Healthcare · Current price ₹1,783.2
P/E ratio
36.6x
P/B ratio
7.1x
ROE
20.1%
ROCE
24.0%
Debt / Equity
0.31
Dividend yield
0.2%
Ratio reference
| Ratio | Value | What it means |
|---|---|---|
| P/E | 36.6x | Price paid per ₹1 of annual earnings — lower is cheaper (context-dependent). |
| P/B | 7.1x | Price relative to book value — <1 can signal deep value or trouble. |
| ROE | 20.1% | Return on equity — how much profit the company earns on shareholder capital. |
| ROCE | 24.0% | Return on capital employed — efficiency including debt. >15% is strong. |
| D/E | 0.31 | Leverage — higher means more debt-funded, riskier in downturns. |
Model it yourself — PEG Ratio Calculator
Opens pre-filled with EMCURE PHARMACEUTICALS L's latest numbers.
EMCURE PHARMACEUTICALS L profitability
EMCURE PHARMACEUTICALS L generates a return on equity of 20.1% and a return on capital employed of 24.0%. An ROE consistently above 15% usually points to a quality business with a durable advantage; below 10% suggests weak profitability or a capital-heavy model.
Leverage & valuation
With a debt-to-equity of 0.31 and a P/E of 36.6x, EMCURE PHARMACEUTICALS L is conservatively financed. Our overall business-quality score for the company is 5.2 / 10.
Understand the ratios
More on EMCURE PHARMACEUTICALS L
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.